ScholarIQanswers from OpenAlex

Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis

PaperCitations, authors & open-access status

Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis have?

ScholarIQcitation count

Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis has 58 citations in the OpenAlex counts ScholarIQ stores.

When was Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis published?

ScholarIQyear

Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis has 2013 year in the ScholarIQ index.

What is the open-access status of Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis?

ScholarIQoa status

Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis has closed oa status in the ScholarIQ index.

What is the DOI of Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis?

ScholarIQdoi

The DOI for Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis is on the source record.

What is the PMID of Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis?

ScholarIQpmid

The PMID for Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis is on the source record.

What is the OpenAlex record for Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis?

ScholarIQopenalex

The OpenAlex for Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial